Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells

(2014) H. J. J. van der Vliet et al.   JOURNAL OF IMMUNOLOGY

CD1d expression on and regulation of murine hematopoietic stem and progenitor cells

(2012) H. E. Broxmeyer et al.   BLOOD

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma

(2012) S. R. Mattarollo et al.   BLOOD

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors

(2012) Karsten A. Pilones et al.   Clinical & Developmental Immunology

Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells

(2011) Aaron J. Tyznik et al.   CHEMISTRY & BIOLOGY

Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis

(2011) Sandrine Aspeslagh et al.   EMBO JOURNAL

Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of α-galactosylceramide

(2010) Hetty J. Bontkes et al.   CLINICAL IMMUNOLOGY

Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation

(2010) T. Iyoda et al.   INTERNATIONAL IMMUNOLOGY

Efficient Isolation of Mouse Liver NKT Cells by Perfusion

(2010) Xianfeng Fang et al.   PLoS One

Harnessing CD1d-Restricted T Cells toward Antitumor Immunity in Humans

(2009) Natalia Neparidze et al.   Annals of the New York Academy of Sciences

Natural Killer T Cells and Autoimmune Disease

(2009) Lan Wu et al.   CURRENT MOLECULAR MEDICINE

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities

(2009) L. Wu et al.   TISSUE ANTIGENS

Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with α-galactosylceramide in vivo

(2008) Yuki Tamura et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Regulation of multiple myeloma survival and progression by CD1d

(2008) E. Spanoudakis et al.   BLOOD

Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy

(2008) W. Song et al.   CLINICAL CANCER RESEARCH

Methods for detection, isolation and culture of mouse and human invariant NKT cells

(2007) Hiroshi Watarai et al.   Nature Protocols